#3560
Nutritional status in patients with neuroendocrine tumors: A single ENETS Centre of Excellence experience
Introduction:
Studies show that 14–68% of patients with neuroendocrine tumors (NETS) are at risk of or are malnourished. Patients’ dependent on NET type, primary or treatment are at risk of Vitamin B12, A, D E, iron deficiencies, pancreatic enzyme insufficiency (PEI) and a high HbA1c.
Conference:
Presenting Author:
Authors:
Burke D,
Almeamar H,
O'Toole D,
Barnes L,
Crowley R,
Keywords:
malnutrition,
deficiencies,
Pancreatic enzyme insufficiency,
HbA1c's,
#175
The Immunohistochemical (IHC) Expression and Prognostic Value of ER, PR, and HER2/neu in Pancreatic and Small Intestinal Neuroendocrine Tumors
Introduction:
There has been limited study of ER and PR expression in gastrointestinal neuroendocrine tumors (GINETs) and data on HER2/neu overexpression in GINETS has been conflicting.
Conference:
8th Annual ENETSConcerence (2011)
Presenting Author:
Authors:
Rayson D,
Arnason T,
Barnes P,
Drewniak M,
Abdolell M,
Keywords:
progesterone receptor,
her2/neu,
ginets,
tissue microarray,
#174
Loss of Expression of the DNA Mismatch Repair Proteins MLH1 and MSH2 is Rare in Pancreatic and Small Intestinal Neuroendocrine Tumors
Introduction:
Loss of expression of the DNA mismatch repair (MMR) proteins MLH1 and MSH2, which is known to correlate strongly with MSI, has not been well studied in pancreatic or small intestinal NETs.
Conference:
8th Annual ENETSConcerence (2011)
Presenting Author:
Authors:
Rayson D,
Arnason T,
Sapp H,
Barnes P,
Drewniak M,
Keywords:
microsatellite instability,
tissue microarray,
pnets,
small intestinal nets,